A comprehensive analysis of excess depressive disorder in women and men living with HIV in France compared to the general population.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
16 04 2022
16 04 2022
Historique:
received:
10
12
2021
accepted:
30
03
2022
pubmed:
18
4
2022
medline:
20
4
2022
entrez:
17
4
2022
Statut:
epublish
Résumé
We aimed to estimate the prevalence of depressive disorder in people living with HIV (PLWH) and evaluate its association with non-HIV-specific and HIV-specific factors in PLWH and in PLWH compared to the general population (GP). We used cross-sectional data from the QuAliV study, conducted within the ANRS-CO3 Aquitaine-AQUIVIH-NA cohort of PLWH in Nouvelle-Aquitaine (2018-2020), and a nationally-representative survey in the GP (EHIS-ESPS, 2014-2015), we included all participants aged ≥ 18 years old who had completed the Patient Health Questionnaire-8 (PHQ-8). Depressive disorder was defined as Patient Health Questionnaire-8 score greater or equal to 10. Its association with non-HIV-specific (demographic, socio-economic, behavioral, health status), HIV-specific factors (immuno-viral markers, antiretrovirals, level of perceived HIV-stigma), and HIV-status was assessed using Poisson regression models with robust variance in women and men separately. We included 914 PLWH (683 men/231 women). More than one in five PLWH had depressive disorder. It was strongly associated with being younger and experiencing severe pain in both sexes. Unemployment in women, being single, and lack of family ties in men were also associated with depressive disorder. More than 30% of our sample reported HIV-stigma, with a dose-response relationship between level of perceived HIV-stigma and depressive disorder. The crude prevalence of depressive disorder was 2.49 (95%CI 1.92-3.22) and 4.20 (95%CI 3.48-5.05) times higher in women and men living with HIV respectively compared to GP counterparts and 1.46 (95%CI 1.09-1.95) and 2.45 (95%CI 1.93-3.09) times higher after adjustment for non-HIV specific factors. The adjusted prevalence ratio of depressive disorder was not significantly different in HIV-stigma free women, but remained twice as high in HIV-stigma free men. The prevalence of depressive disorder compared to the GP tended to decrease with age in PLWH. Excess depressive disorder remains a major concern in PLWH. Our findings reaffirm the importance of regular screening. Tackling social inequalities and HIV-stigma should be prioritized to ensure that PLWH achieve good mental as well as physical health outcomes.
Identifiants
pubmed: 35430622
doi: 10.1038/s41598-022-10263-3
pii: 10.1038/s41598-022-10263-3
pmc: PMC9013369
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
6364Informations de copyright
© 2022. The Author(s).
Références
N Engl J Med. 2015 Aug 27;373(9):795-807
pubmed: 26192873
BMJ Open. 2016 Jul 13;6(7):e011453
pubmed: 27412106
BMC Med. 2016 Jun 22;14(1):94
pubmed: 27334606
Am J Public Health. 2017 Jun;107(6):863-869
pubmed: 28426316
AIDS Care. 2018 Jul;30(7):807-816
pubmed: 29284284
HIV Med. 2017 Jul;18(6):383-394
pubmed: 27625202
Clin Infect Dis. 2020 Jul 11;71(2):293-300
pubmed: 31612225
Int J Drug Policy. 2021 May;91:103101
pubmed: 33494013
AIDS. 2017 Jun 19;31(10):1471-1481
pubmed: 28574965
AIDS Behav. 2021 Dec;25(12):4209-4224
pubmed: 34036459
HIV Med. 2014 Sep;15(8):458-69
pubmed: 24589241
HIV Med. 2020 Nov;21(10):617-624
pubmed: 32885559
Cochrane Database Syst Rev. 2017 Mar 14;3:CD010806
pubmed: 28291302
HIV Med. 2019 May;20(5):317-329
pubmed: 30924577
Lancet HIV. 2017 Aug;4(8):e349-e356
pubmed: 28501495
BMC Infect Dis. 2020 Nov 16;20(1):850
pubmed: 33198667
J Clin Psychiatry. 2012 Mar;73(3):384-91
pubmed: 22053858
PLoS One. 2013 Sep 03;8(9):e73180
pubmed: 24019904
J Acquir Immune Defic Syndr. 2015 Sep 1;70(1):16-22
pubmed: 26017659
AIDS. 2013 Jan 28;27(3):391-400
pubmed: 23079813
J Clin Med. 2021 Feb 11;10(4):
pubmed: 33670229
Lancet HIV. 2014 Oct;1(1):e32-40
pubmed: 26423814
HIV Med. 2017 Feb;18(2):89-103
pubmed: 27385511
PLoS One. 2014 Mar 24;9(3):e92842
pubmed: 24663122
Lancet. 2013 Nov 2;382(9903):1525-33
pubmed: 24152939
J Affect Disord. 2009 Apr;114(1-3):163-73
pubmed: 18752852
JMIR Res Protoc. 2018 Jun 07;7(6):e147
pubmed: 29880467
Sex Transm Infect. 2021 Dec;97(8):613-618
pubmed: 33431606
J Neurovirol. 2013 Aug;19(4):314-27
pubmed: 23868513
Clin Infect Dis. 2019 Jan 18;68(3):475-481
pubmed: 29901695
Clin Infect Dis. 2010 Apr 15;50(8):1165-73
pubmed: 20210646
Clin Infect Dis. 2014 Dec 15;59(12):1787-97
pubmed: 25182245
Alcohol Clin Exp Res. 2007 Feb;31(2):185-99
pubmed: 17250609
BMC Med Res Methodol. 2003 Oct 20;3:21
pubmed: 14567763